Eqis Capital Management, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Eqis Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 06, 2018	SELL	$52.16 - $66.86 $327,669 - $420,014	-6,282 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$49.6 - $60.87 $2,529 - $3,104	51 Added 0.82%	6,282 $336,000
Q3 2017 Oct 03, 2017	BUY	$46.62 - $60.36 $290,489 - $376,103	6,231	6,231 $372,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.